Key result
A single oral dose of diazepam decreased delta P0.1/delta PETCO2 values compared to placebo, whereas zopiclone had no effect, with no significant difference between the two.
Why the study?
Does a single oral dose of diazepam or zopiclone alter respiratory center output in patients with moderate to severe chronic obstructive pulmonary disease?
RCT (n=32)
Double-blind
Latin-square design
Does a single oral dose of diazepam or zopiclone alter respiratory center output in patients with moderate to severe chronic obstructive pulmonary disease?
A single oral dose of diazepam, but not zopiclone, significantly decreases respiratory center output in response to hypercapnia in patients with moderate to severe COPD.
This is the authors' abstract. We don't add key points for this paper.
Mouth occlusion pressure at 0.1 s (P0.1) and minute ventilation (VE) were measured at rest and during progressive hypercapnia in 32 patients. Under double-blind conditions and according to a 2 x 2 Latin-square design, half the patients received one oral dose of diazepam and its placebo. Using the same design, the other half received zopiclone and its placebo. Normocapnic and moderately hypoxemic patients between the ages of 21 and 69 with moderate to severe chronic obstructive pulmonary disease were included in the study. Diazepam produced a statistically significant decrease (p less than 0.05) over its placebo in delta P0.1/delta PETCO2 values following CO2 rebreathing. Zopiclone did not influence either delta P0.1/delta PETCO2 or delta VE/delta PETCO2, but produced a significant increase in respiratory frequency. However, no statistically significant differences were observed between the two active treatments.
Answers are grounded in this paper and cite their sources.
Diazepam but not zopiclone blunts hypercapnic respiratory drive in COPD; warrants caution with benzodiazepines and extends RCT data on sedative selectivity.
No takes yet. Share an insight, caveat, or question.
Beaupré et al. (2009) conducted an RCT in Chronic obstructive pulmonary disease (n=32). Diazepam and Zopiclone vs. Placebo was evaluated on delta P0.1/delta PETCO2 values following CO2 rebreathing (p=<0.05). A single oral dose of diazepam decreased delta P0.1/delta PETCO2 values compared to placebo, whereas zopiclone had no effect, with no significant difference between the two.
Synapse has enriched 10 related papers. Consider them for comparative context: